dose of retatrutide Dosage: Week-to-Week Schedule & Chart Retatrutide Dosage Calculator: How Dosing

Secondary 2026 analyses attribute retatrutide's reported hepatic fat reduction of up to 86% to this glucagon arm, though the primary MASLD endpoint paper is [unverified] in this dataset [1]

All GLP-1 class drugs cause some degree of lean mass loss alongside fat loss, and this is a legitimate concern for anyone optimizing for longevity rather than just the number on the scale

After hearing anecdotes of patients on the diabetes and obesity drugs experiencing nonarteritic anterior ischemic optic neuropathy, or NAION, researchers at Massachusetts Eye and Ear analyzed data from a registry of patients at their institution to see if there was a broad trend

Diabetes (1995) 44:12028

Pharmaceutical Manufacturing and Supply Chain Challenges With rising demand for obesity and diabetes drugs, manufacturers face significant challenges: API shortages due to limited global supply

Global prevalence of pancreatic cystic lesions in the general population on magnetic resonance imaging: a systematic review and meta-analysis